New cancer drugs approved faster in U.S. than Europe
New oncology therapies generally are approved more quickly in the United States than in Europe, according to a study published online June 10 in JAMA Network Open.
Jun 14, 2022
0
3
New oncology therapies generally are approved more quickly in the United States than in Europe, according to a study published online June 10 in JAMA Network Open.
Jun 14, 2022
0
3
When you take a time-release drug, you count on it doing what the package says: release the drug slowly into your bloodstream to provide benefits over the specified period of time. When the drug dissolves too slowly or too ...
Nov 24, 2020
0
28
Watching Alzheimer's disease steal away the memory, talents and very selves of its victims is hard enough for the people who love them. But a new pill formulated by a respected pharmaceutical company and approved by the Food ...
Mar 23, 2012
0
0
(HealthDay)—The first generic versions of the atypical antipsychotic drug Abilify (aripiprazole) have been approved by the U.S. Food and Drug Administration to treat schizophrenia or bipolar disorder.
Apr 30, 2015
0
8
(Medical Xpress)—Research that aims to rid dementia sufferers' brains of toxins could lead to a new treatment that reverses the symptoms of Alzheimer's disease in the future.
Feb 8, 2013
0
0
(Medical Xpress)—Before joining Washington University in St. Louis, Michael Kinch, PhD, was managing director of the Center for Molecular Discovery at Yale University. "A few years ago, to motivate the team I gave them ...
Sep 23, 2014
0
1
Fibroblasts, cells that play a role in the structural framework of tissues, play an apparent role in melanoma tumor growth. Fibroblasts also contribute to melanoma drug resistance and may also facilitate the "flare" response ...
Jan 5, 2012
0
0
Development of new drugs for treatment of disease is an expensive, time-consuming and labour-intensive effort for both pharmaceutical companies and academics. For the past 15 years, "cost per approval" of new drugs has increased ...
Oct 28, 2014
0
0
In 1998, when Timothy Hla, Ph.D., and his colleagues identified and cloned the receptor for sphingosine-1-phosphate (S1P), it generated a lot of excitement. S1P, a lipid originally discovered in the 1960s, was known to play ...
Mar 11, 2020
0
79
Most synthetic chemical products used in consumer goods end up unchanged in the environment. Given the risks this could pose for the environment and human health, researchers from the Autonomous University of Barcelona (UAB) ...
Jul 28, 2011
0
0